- Home
- IMNM vs GES Comparison
IMNM vs GES Comparison
Compare IMNM & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- GES
- Stock Information
- Founded
- IMNM 2006
- GES 1981
- Country
- IMNM United States
- GES Switzerland
- Employees
- IMNM N/A
- GES N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- GES Apparel
- Sector
- IMNM Health Care
- GES Consumer Discretionary
- Exchange
- IMNM Nasdaq
- GES Nasdaq
- Market Cap
- IMNM 987.1M
- GES 879.0M
- IPO Year
- IMNM 2020
- GES 1996
- Fundamental
- Price
- IMNM $13.83
- GES $16.80
- Analyst Decision
- IMNM Strong Buy
- GES Buy
- Analyst Count
- IMNM 9
- GES 5
- Target Price
- IMNM $24.89
- GES $19.25
- AVG Volume (30 Days)
- IMNM 2.0M
- GES 534.2K
- Earning Date
- IMNM 11-12-2025
- GES 11-25-2025
- Dividend Yield
- IMNM N/A
- GES 5.35%
- EPS Growth
- IMNM N/A
- GES N/A
- EPS
- IMNM N/A
- GES 0.35
- Revenue
- IMNM $12,589,000.00
- GES $3,091,508,000.00
- Revenue This Year
- IMNM N/A
- GES $7.74
- Revenue Next Year
- IMNM $154.70
- GES $3.47
- P/E Ratio
- IMNM N/A
- GES $48.53
- Revenue Growth
- IMNM 16.74
- GES 7.84
- 52 Week Low
- IMNM $5.15
- GES $8.48
- 52 Week High
- IMNM $15.13
- GES $19.91
- Technical
- Relative Strength Index (RSI)
- IMNM 67.38
- GES 67.26
- Support Level
- IMNM $11.25
- GES $16.67
- Resistance Level
- IMNM $12.00
- GES $16.89
- Average True Range (ATR)
- IMNM 1.01
- GES 0.08
- MACD
- IMNM 0.40
- GES -0.11
- Stochastic Oscillator
- IMNM 87.06
- GES 59.09
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.